CAMBRIDGE, England--(BUSINESS WIRE)--TeraView, (http://www.teraview.com/) the pioneer and leader in Terahertz technology and solutions for the pharmaceutical and life science industries, says its Terahertz imaging and spectroscopy products can be used in conjunction with wet dissolution testing to accelerate product development of tablets and capsules, and maintain in-spec performance during pharmaceutical manufacture. The announcement comes in the wake of a recent paper by the Food and Drug Administration (FDA) in the US, which states that the speed and ease of Terahertz imaging may make it an attractive potential replacement for wet dissolution testing both in product development and eventually for process analysis.
